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ABSTRACT 17 
Gelatin hydrogels have great potential in regenerative medicine but their weak mechanical properties 18 
are a major drawback for the load-bearing applications, such as scaffolds for tissue engineering. To 19 
overcome this deficiency, novel biodegradable hydrogels with improved mechanical properties were 20 
prepared by combining gelatine with 2-hydroxyethyl methacrylate (HEMA), using a double 21 
network synthetic procedure. The first, superporous and mechanically strong network, was obtained 22 
by free radical polymerization of HEMA at cryogenic temperature, in the presence of gelatin.  23 
Degradable poly(β-amino ester) (PBAE) macromers of different chemical composition or molecular 24 
weight were used as crosslinkers to introduce hydrol tically labile bonds in PHEMA. The second 25 
gelatin network was formed by crosslinking gelatin with glutaraldehyde. For comparison, a set of 26 
biodegradable PHEMA networks was obtained by polymerization of HEMA at cryogenic 27 
temperature. All samples were characterized revealing that mechanical strength, swelling behavior 28 
and degradation rate as well as high biocompatibility of new IPNs are in accordance with values 29 
required for scaffolds in tissue engineering applications and that tuning of these properties is 30 


















1. INTRODUCTION  37 
 38 
Hydrogels are slightly crosslinked hydrophilic polymers that swell and can hold varying amounts of 39 
water, but do not dissolve. Their rapidly increasing use in biomedical applications, such as drug 40 
delivery and tissue engineering biomaterials, is due to their consistency, high water content and soft 41 
texture, which is very similar to natural living soft tissues. Besides, there is a possibility to tune the 42 
hydrogel biocompatibility, chemical and physical pro erties for the targeted applications using 43 
different components and synthetic procedures. In recent years an increasing interest for highly 44 
porous biodegradable polymeric hydrogels arose in the development of advanced tissue engineering 45 
materials, such as implants and scaffolds in tissue engineering. Biodegradability is required in order 46 
to avoid the need for second surgery [1]. The conjugation of biological and synthetic materials, 47 
which are similar to the extracellular matrix (ECM) components, is a good way to produce the 48 
hydrogel scaffolds that mimic natural ECM for the tissue engineering and regenerative medicine 49 
applications [2, 3]. In this respect biodegradable components, as gelatin and HEMA, can be 50 
considered as a good combination for hybrid hydrogel scaffolds in tissue regeneration, as they 51 
consolidate the benefits of a natural and synthetic polymer. Gelatin, as an enzymatically 52 
biodegradable polymer which introduces biological cues in the scaffold, is reinforced by PHEMA 53 
hydrogel, crosslinked with hydrolytically degradable crosslinkers. Synthetic polymers, such as 54 
PHEMA, also allow tuning of physical and chemical properties of hybrid hydrogel [4].  55 
Gelatin gained much attention as scaffold material due to excellent biocompatibility, 56 
biodegradability, low immunogenicity, availability, easy handling and low cost [5].  PHEMA is a 57 
synthetic polymer which is nontoxic and has good biocompatibility, chemical stability, mechanical 58 
properties and elasticity, as well as a relatively high degree of hydration, but it is not biodegradable 59 
and cannot be eliminated from the body [6]. There aseveral examples in the literature of 60 
introducing labile linkages in HEMA to obtain biodegradability [7, 8]. Huang et al [7] designed 61 
degradable, elastomeric PHEMA/hydroxyapatite biocomp sites using a degradable crosslinker 62 
(macromer) dimethacrylated triblock copolymers, poly(lactide-b-ethylene glycol-b-lactide) (PLA-b-63 
PEG-b-PLA) which disintegrate by hydrolytic degradation [9, 10]. Moghadam et al [8] used N,O-64 
dimethacryloyl hydroxylamine (DMHA), sensitive to hydrolytic cleavage, to fabricate 65 
biodegradable PHEMA hydrogels. The use of synthetic PBAE macromers as degradable 66 
crosslinkers was only investigated for the synthesis of P(HEMA/NVP) copolymers by R A. McBath 67 
and D. A. Shipp, but they investigated only the swelling and degradation properties and did not 68 
suggest any application of these hydrogels [11].  69 
PBAEs display numerous advantages, including good bi compatibility, simple synthetic procedure, 70 
and pH and temperature sensitive swelling and degraation [12, 13]. A wide range of different, 71 













component, or their ratio. PBAEs have a large variety of applications including encapsulation and 73 
delivery of biological molecules, as nanocarriers for mRNA [14] and DNA [15], antioxidans [16] 74 
and drugs for cancer [17] and cartilage treatments [18].  Although synthetic PBAE macromers 75 
found numerous applications in medicine and pharmacy, their use was focused on the synthesis of 76 
PBAE polymers and copolymers [19-20]).   77 
 78 
In recent years biodegradable macroporous polymeric hydrogels have become highly important in 79 
the field of biomaterials and tissue engineering. They have attracted much attention, particularly in 80 
applications such as 3D scaffolds for the repair and regeneration of injured tissue, as templates for 81 
tissue regeneration which guide the growth of new tissue. A scaffold should have an open-cell 82 
structure with different pore sizes, improving both cell proliferation and vascularization and also 83 
providing the exchange of liquids and nutrients for cell survival [21]. Due to biodegradable property 84 
a need for additional surgeries to remove the implants or scaffold is avoided [22]. 85 
The novelty of this work is that gelatin and HEMA, crosslinked with PBAE macromers, were used 86 
for the first time to prepare scaffolds for tissue engineering applications, as a combination of natural 87 
and synthetic polymer which is producing new materil with tailored functional properties. The 88 
double network sequential synthetic procedure at cryogenic conditions was used to obtain the 89 
superporous IPNs with interconnected pores, as a uniform mixture of these polymers. The second 90 
set of biodegradable simple networks was obtained un er the same conditions, by free radical 91 
polymerization of HEMA crosslinked with PBAE macromers. The aim of this study was to tune the 92 
degradation and mechanical properties of IPNs, by simply changing the type and/or molecular 93 
weight of PBAE macromer. The characterization of samples for their chemical composition, 94 
morphology, porosity, swelling, and mechanical properties as well as for degradation behaviour and 95 
cytotoxicity studies confirmed that PHEMA/gelatin IPNs would be suitable for potential application 96 
as scaffolds for tissue engineering.     97 
 98 
 99 
2. MATERIALS AND METHODS 100 
 101 
2.1. Materials 102 
Piperazine (PIPz, 99%), HEMA, di(ethylene glycol) diacrylate (DEGDA), 1,6-hexanediol diacrylate 103 
(HDDA) and gelatin (porcine, type A) were purchased from Aldrich.  Poly(ethylene glycol) 104 
diacrylate ((PEGDA) average Mn 400) was purchased from Polysciences (Hirschberg, Germany). 105 
Potassium persulfate (KPS, Aldrich), as initiator, and N,N,N′,N′-tetramethylethylene diamine 106 
(TEMED, Aldrich), as activator, were used in all polymerizations performed in cryogenic 107 













for buffer preparations. Deionized water was used for all polymerizations and the preparation of 109 
buffer solution. 110 
 111 
2.2. PBAE macromer synthesis 112 
PBAE (CL1 and CL2) macromers (Scheme 1) were synthetized by Michael addition of DEGDA 113 
and piperazine, according to the previously described procedure [11]. PBAE macromers were used 114 
without any further purification. 115 
PBAE macromer CL1 was synthesized by vigorous stirring of DEGDA soluti n (3 mL in 3mL 116 
CHCl3) at 25°C, to which was added piperazine solution (0.622 g in 3 mL CHCl3) in 3 equivalent 117 
portions, at 0, 12 and 24 h. The molar ratio of diacrylate to piperazine was 1.8/1. The stirring was 118 
continued for additional 24 h. The solvent was then evaporated from the reaction mixture, leaving a 119 
yellow viscous fluid. 120 
 121 
Sheme 1. Synthesis of CL1 and CL2 macromers. 122 
 123 
PBAE macromer CL2 was synthesized by vigorous stirring of DEGDA soluti n (10 mL in 5 mL 124 
CHCl3) at 25°C, with adding piperazine solution (3.685 g in 5 mL CHCl3). The molar ratio between 125 
diacrylate and piperazine was 1.2/1. The stirring was continued for additional 6 h. The solvent was 126 
then evaporated from the reaction mixture, leaving a dark yellow viscous fluid. 127 
 128 
PBAE macromer CL3 (Scheme 2) was synthesized by stirring 1,6-hexanedioldiacrylate solution 129 
(7.30 g, 0.0259 mol, in 6 mL CHCl3) at 50°C, and adding piperazine solution (1.24 g, 0.0144 mol, 130 
in 6 mL CHCl3) in 3 equivalent portions, at 0, 12 and 24 h. The molar ratio of diacrylate to 131 
piperazine was 1.8/1. The stirring at 50°C was continued for additional 24 h. The solvent was then 132 
evaporated from the reaction mixture, leaving a pale yellow viscous fluid.  133 
 134 
Sheme 2. Synthesis of CL3 macromer. 135 
 136 
2.2. PBAE characterization 137 
Chemical structure of poly (beta amino) esters was determined using 1H NMR spectra, recorded on 138 
a Bruker Ultrashield Advance III spectrometer (at 500 MHz), using CD3Cl as solvent and TMS as 139 
the internal standard.  140 
 141 
2.3. Cryogel syntesis (without gelatin) 142 
The cryogels were obtained by free radical polymerization at cryogenic temperatures. HEMA (1.29 143 













deionized water, using APS as initiatior and TEMED as activator. The reaction mixture was purged 145 
with nitrogen for 10 minutes, poured into petri dish (5 cm radius, 0.5 cm height) and cooled to -20 146 
°C for 24 h. After thawing the cryogel at room temperature, it was cut into discs and washed with 147 
deionized water for 7 days in order to remove impurities. Water was changed daily. Swollen 148 
cryogels were frozen and freeze-dried. 149 
 150 
2.4. Cryogel synthesis (with gelatin) 151 
PHEMA/gelatin cryogels were obtained by free radical polymerization, using APS as initiator and 152 
TEMED as activator. HEMA (1.29 g, 9.8 mmol), PBAE macromers or PEGDA (15 % w/w for 153 
HEMA) and gelatin (300 mg) were dissolved in 5 mL of deionized water, by stirring at 40°C. This 154 
mixture was purged with nitrogen for 15 min, poured into petri dish (5 cm radius, 0.5 cm height) 155 
and cooled to -20°C for 24 h. After thawing the cryogel at room temperature, it was cut into discs 156 
which were submerged in 4% glutaraldehyde solution overnight, in order to crosslink gelatin (Fig. 157 
1). Cryogel samples were washed with deionized water for 7 days to remove impurities. Water was 158 
changed daily. Swollen cryogels were frozen and freeze-dried. The cryogels were designated as in a 159 
following table (Table 1). 160 
 161 
 162 
Fig. 1. Semi-IPN and IPN synthesis.  163 
 164 
Table 1. The composition and designation of cryogels. 165 
Cryogel Monomer(s) Crosslinker 
CG1 HEMA CL1 
CG2 HEMA CL2 
CG3 HEMA CL3 
CG4 HEMA PEGDA 
CG5 HEMA, gelatin CL1 
CG6 HEMA, gelatin CL2 
CG7 HEMA, gelatin CL3 
CG8 HEMA, gelatin PEGDA 
 166 
2.5. Hydrogel characterization 167 
Hydrogel composition was analysed using FTIR spectra, recorded on a Thermo-Scientific Nicolet 168 
6700 FT-IR diamond crystal spectrometer, using the Att nuated total reflectance (ATR) sampling 169 














2.6. Swelling studies   172 
Degree of swelling (qe) for the cryogels was determined using the gravimetric method. Dry cryogel 173 
discs were immersed in buffer solution (phosphate buffer, pH 7.4) at 37 °C, mimicking 174 
physiological conditions, for 24 hours. Discs were periodically removed from the buffer solution, 175 
dried by blotting on paper to remove excess water, nd weighted. Degree of swelling was calculated 176 







Where mi is the initial weight of the dry cryogel, and ms was the weight of the swollen cryogel at 180 




2.7. Mechanical Testing 185 
Mechanical characteristics of the scaffolds were measured with universal testing machine 186 
(Galdabini Quasar 50, Italy) by the application of a uniaxial compression with 100-N load cell at 187 
room temperature. The Young’s modulus (E) was calcul ted from the linear part of the stress/strain 188 
curve and its final value is an average of three measurements. 189 
 190 
2.8. Morphology   191 
The morphological analysis was performed with scanning electron microscopy (Jeol JSM-7600F). 192 
Samples were cut into slices, fixed on holder using carbon tape, sputtered with gold (using BAL-193 
TEC SCD 005) and dried in vacuum chamber (VC 50 SalvisLab Vacucenter). Observation was 194 
performed for cross sections of the scaffolds. 195 
 196 
2.9. Porosity measurement 197 
Porosity of cryogels was determined by solvent replacement method. Glycerol (ρ = 1,2038 g/cm3) 198 
was used as a wetting medium. Dried cryogels were submerged in glycerol for 24 hours, and 199 









Where mi is the initial weight of the dry cryogel, mglycerol is the weight of the cryogel with glycerol, 203 














2.10. Degradation studies 206 
In vitro hydrolytic degradation studies were conducted by submerging cryogel samples in phosphate 207 
buffer solution (pH 7.4 at 37 °C). Samples were taken out of the buffer solution at every two weeks, 208 
dried at 40°C until constant mass, and measured. Degradation was presented as a function of 209 










Where mi is the initial weight of the dry cryogel, and mt is the weight of the dried cryogel sample at 213 
the time of measuring. 214 
 215 
2.11. Biocompatibility assay 216 
To evaluate the biocompatibility of the novel cryogels is the first step in evaluation of newly 217 
synthesized molecules. For the biocompatibility assay in this study normal human fibroblast cells, 218 
MRC5, were used. The synthesized cryogels were cultivated in the cell culture media in 24-well 219 
microtiter plate during 24 hours. After this incubation period supernatants were centrifuged and 220 
used for biocompatibility assay. The MRC5 cells were maintained in Dulbecco’s modified Eagle’s 221 
medium supplemented with 10% fetal bovine serum. Cells were grown in culture bottles supplied 222 
with medium for cultivation, and thereafter cells were seeded in 96-well plate. MRC5 cells seeded 223 
in 96-well microtiter plate and cultivated in the full culture media in a humidified atmosphere of 5% 224 
CO2 at 37°C during 24 hours. The next 24 hours the MRC5 cells were incubated both with and 225 
without prepared supernatants of the investigated hydrogels. At the end of this period modified 226 
MTT method [23] was used for measuring the cell viability/proliferation. This test is based on the 227 
color reaction of mitochondrial dehydrogenase from living cells with MTT. Briefly, 10 µL of MTT 228 
solution (5 mg mL−1) was added to each well after clls treatment and cells were incubated for 229 
additional 3 hours at 37°C. Produced formazan was dissolved by overnight incubation with sodium 230 
dodecyl sulfate (SDS)-HCl mixture (10% SDS in 0.01 N HCl) and absorbance was measured at 231 
dual wavelength of 570/650 nm with an enzyme-linked immunosorbent assay (ELISA) 96-well 232 
plate reader. The percentage of viable cells was calculated as the ratio between absorbance at each 233 
dose of the compounds and absorbance of untreated control cells ×100. 234 
 235 
3. RESULTS AND DISCUSSION  236 
 237 













PBAE macromers, a class of biodegradable and biocompatible materials, were polymerized using 239 
the reaction of acrylates with amines, i.e. Michael ddition, which proceeds via stepwise reaction. 240 
This reaction is easy to conduct and does not requi any purification steps. 241 
In this work different PBAEs macromers were synthesized using an addition reaction of the same 242 
amine component, piperazine, with two different diacrylates, di (ethylene glycol) diacrylate and 1,6-243 
hexanediol diacrylate. As the diacrylate to diamine molar ratio was >1 in all samples, the final 244 
macromers had acrylate end groups, permiting free radical polymerization or copolymerization 245 
reaction and crosslinking of monomers, in order to prepare simple polymer networks [24]. Using 246 
diacrylates DEGDA and HDDA with different hydrophilic properties, different macromer 247 
hydrophilicity was obtained. As macromer hydrophilicity affects the swelling/degradation behavior, 248 
this property can be used to tune the degradation rate. The HDDA/piperazine ratio was 1.8/1. In 249 
order to obtain corresponding mechanical properties and degradation rates the DEGDA/piperazine 250 
molar ratio was varied (1.2/1 and 1.8/1). This afforded different molecular weights of macromers, 251 
providing variation in crosslinking densities and mechanical strength.  252 
The 1H NMR spectra of PBAE CL1 confirmed that the synthetized PBAE macromers are pu and   253 
possess acrylate groups at the chain ends (Fig. 2). Determination of number-average molecular 254 
weight of PBAE macromers was achieved by comparing the integrated NMR data of two end group 255 
protons (vinyl protons of acrylate groups – 6 protons in 2 vinyl groups), with characteristic protons 256 
found in the repeating unit of the monomer (ethylene proton peaks of ethylene glycol in DEGDA 257 
and HDDA) [25]. 258 
 259 
Fig. 2. 1H NMR spectra of CL1 macromer, with comparison of peak integral values.  260 
 261 
By comparing the integral value of vinyl proton peaks (5.7 - 6.5 ppm) with those of ethylene proton 262 
peaks (3.5 - 4.4 ppm) from ethylene glycole fragment, for CL1 and CL2 and ethylene proton peaks 263 
(4.0-4.2 ppm) for CL3, the number-average molecular weight of poly beta amino ester macromers 264 
was calculated. Number-average molecular weights were as follows: 583 g/mol for CL1, 2944 265 
g/mol for CL2 and 603 g/mol for CL3.  266 
 267 
3.2. Hydrogel synthesis 268 
Two series of highly porous hydrogel networks, simple PHEMA and PHEMA/gelatin IPNs, were 269 
successfully synthesized. 270 
 271 
3.3. Hydrogel characterization 272 
 273 
Comparing the FTIR spectra of PBAE macromer CL1 and cryogels CG1 and CG5 (Fig. 3), the 274 













cm-1) can be observed in spectra of both cryogel samples [26]. This shows that vinyl end groups 276 
were converted into ethylene groups from PBAE macromers. Observable bands in CG1 cryogel 277 
spectra are at – 3415 cm-1 for O-H stretching, 2944 cm-1 for C-H stretching of alkyl groups and 278 
1722 cm-1 for C=O stretching of ester carbonyl group. In spectra of CG5 cryogel observable bands 279 
are 3324 cm-1 for O-H and N-H stretching, 2944 cm-1 for C-H stretching of alkyl groups, 1722 cm-1 280 
for C=O stretching of ester carbonyl group, 1653 cm-1 for C=O stretching of amide group (amide I), 281 
and 1549 cm-1 for N-H bending vibrations of amid group in gelatin (amide II) [27]. 282 
 283 
 284 
Fig. 3. Comparison between FTIR spectra of crosslinker CL1 and cryogels CG1 and CG5. 285 
 286 
3.4. Swelling studies 287 
Swelling capacity of degradable biomaterials is very important and closely connected with their 288 
degradation, because swelling is the first step in the hydrolytic degradation process. In the case of 289 
PHEMA/gelatin IPNs the hydrophilicity of the polymer and macromer chain length as well as the 290 
crosslink density of the networks, influence this process.  291 
Swelling studies were performed in the phosphate buffer solution of pH 7.4 at 370C, that simulates 292 
the physiological conditions. Equilibrium degree of swelling values for simple networks (without 293 
gelatin) and IPNs (with gelatin), are plotted as a function of time (Figs. 4 and 5). 294 
 295 
Fig. 4. Swelling vs time for gels without gelatin. 296 
 297 
Fig. 5. Swelling vs time for gels with gelatin.  298 
 299 
Due to their highly porous structure, mass of all cryogel discs increased abruptly after being 300 
submerged in phosphate buffer solution for less than 10 minutes. The swollen mass of samples 301 
CG1 and CG3 increased by 145% and 89%, respectively, and CG2 by 160%. All cryogels samples 302 
without gelatin reached swelling plateau after 4 hours in accordance with their degree of 303 
hydrophilicity and their superporous structure, with the equilibrium degree of swelling 2.88 ± 0.04 304 
for CG1, 3.38 ± 0.04 for CG2, 2.38 ± 0.03 for CG3 and 2.18 ± 0.03 for CG4. Due to the highly 305 
hydrophilic nature of CL2 monomer and lowest crosslinking density, CG2 absorbed the highest 306 
amount of water. As all PBAE macromers were added in the same amount (15% weight of HEMA 307 
monomer), CL2 was added in lowest molar percentage, resulting in lower crosslinking density, 308 
which also explains its higher swelling degree. CL1 has nearly identical chemical structure as CL2, 309 
but lower molecular weight, resulting in higher crosslinking density, and lower swelling degree of 310 
CG1, compared to CG2. Due to the hydrophobic nature of the hexylene group, CG3 has the lower 311 













CG4 sample, in which PEGDA was used as a crosslinker, showed lower swelling rate compared to 313 
cryogels with PBAE crosslinkers. This can be explained by the positively charged nitrogen in 314 
PBAE crosslinker structure and its higher ability to form hydrogen bonds with water molecules, 315 
making it more hydrophilic than PEGDA. As it can be seen from Figs 4 and 5, samples with gelatin 316 
(CG5 - CG8) swell more than those without gelatin, which can be expected due to gelatin’s highly 317 
hydrophilic nature. Furthermore, as PHEMA/gelatin semi-IPNs are formed during the 318 
crosslinking/polymerization of HEMA with PBAE macromers, gelatin molecules move apart 319 
PHEMA chains, acting as a pore forming agent. Accordingly, larger pores are formed than in the 320 
absence of gelatin, which is also confirmed by SEM micrographs (Fig. 6).  321 
All cryogels with gelatin reached swelling plateau fter 5.5 hours, with the equilibrium degree of 322 
swelling 4.95 ± 0.10 for CG5, 5.92 ± 0.06 for CG6, 4.22 ± 0.08 for CG7 and 3.55 ± 0.07 for CG8. 323 
 324 
3.5. Cryogel morphology 325 
Morphology of the cryogels was observed by Scanning Electron Microscope. Micrographs showed 326 
interconnected polyhedral, elongated pores, with small pores surrounded by polymeric thick walls 327 
of macropores. Samples CG1 and CG3, obtained using macromers CL1 and CL3, with a small 328 
difference in average molecular weight, show similar layout but with smaller pores for CG3, which 329 
is probably due to HDDA diacrylate more hydrophobic nature. Samples CG1 and CG3 both show 330 
small pores interconnected by large canals. CG2 has largest pores, due to longer chain of CL2 331 
macromer than in the case of CG1 and CG3. Cryogel with PEGDA, CG4, showed the smallest 332 
pores due to PEGDA lowest hydrophilicity and lower number-average molecular weight. In 333 
general, cryogels without gelatin (Fig. 6. a, b, c, d) have smaller pores compared to their analogous 334 
IPN cryogels with gelatin (Fig. 6. e, f, g, h), but both series follow the comparable trend for pore 335 
size, which is obviously dictated by the type and nature of the poly(beta amino) ester macromer. 336 
 337 
 338 
Fig. 6. SEM micrographs for cryogels without gelatin (left): CG1 (a), CG2 (b), CG3 (c), CG4 (d) 339 
and with gelatin (right): CG5 (e), CG6 (f), CG7 (g) and CG8 (h). (bar – 200 µm). 340 
     341 
3.6. Porosity measurements  342 
 343 
Convenient pore size is necessary to enable successful cells seeding and diffusion throughout the 344 
matrix of both cells and nutrients. Scaffolds must be permeable with interconnecting pores to 345 
facilitate cell growth, migration and nutrient flow for cell survival, proliferation, and migration [28]. 346 
A relatively high porosity (80–90 %) is also wanted for adequate cell adhesion [29, 30].  The degree 347 
of porosity has a great influence on the mechanical properties with the stiffness of the scaffold 348 














Porosity measurements show an increase of porosity in cryogel samples with gelatin compared to 351 
their analogous samples without gelatin. This trend can be explained by the higher swelling ratio of 352 
cryogels with gelatin, which have a larger water intake, resulting in larger pore formation from ice 353 
crystals during cryogelation. All cryogels containing gelatin show porosity in the range of 80.21-354 
87.04%. Cryogels with CL2 crosslinker displayed the highest porosity, due to the lowest 355 
crosslinking degree (Table 2).   356 
 357 
3.7. Mechanical properties  358 
 359 
The elastic modulus of the scaffolds is a very important physical property because it determines 360 
their use in biomedical applications. Ideally, it should match the mechanical properties of 361 
physiological tissue surroundings were the scaffold is implanted and must be strong enough to 362 
allow surgical handling during implantation [32].   363 
Mechanical properties of our samples considerably depend on the type of crosslinker, showing 364 
similar trends in both sample groups, with and without gelatin (Table 2). Values of Young modulus 365 
obtained for hydrogels based on methacrylamide-modified gelatin and poly(ethylene glycol) [3] or 366 
methacrylamide-modified gelatin and PHEMA [33, 34], fall in the range of 4.4 to 327.7 kPa and in 367 
the case of unmodified gelatin hydrogels even lower values were obtained [35]. In this respect it can 368 
be concluded that considerable increase in Young moduli was achieved by producing new 369 
gelatin/HEMA IPNs, with moduli values in the range of 3.24 - 4.52 MPa. 370 
 371 
Table 2. Equilibrium degree of swelling values, Young’s modulus, porosity, percentage of 372 












on break (%) 
CG1 2.88 ± 0.04 4.38 ± 0.25 73.85 25.95 ± 1.58 24.42 ± 1.32 
CG2 3.38 ± 0.04 3.51 ± 0.21 79.60 32.71 ± 1.65 22.85 ± 1.30 
CG3 2.38 ± 0.03 4.21 ± 0.22 72.49 21.4 ± 1.60 27.73 ± 1.43 
CG4 2.18 ± 0.03 4.76 ± 0.22 66.93 7.14 ± 0.96 28.24 ± 1.42 
CG5 4.95 ± 0.10 4.06 ± 0.20 81.93 20.87 ± 0.94 23.51 ± 1.30 
CG6 5.92 ± 0.06 3.24 ± 0.18 87.04 26.54 ± 0.67 20.26 ± 1.04 
CG7 4.22 ± 0.08 3.96 ± 0.20 82.79 15.95 ± 0.76 25.69 ± 1.32 
CG8 3.55 ± 0.07 4.52 ± 0.24 80.21 4.38 ± 0.81 26.17 ± 1.30 
 374 
The modulus data are presented in Tab. 2. Generally, IPN samples show slightly lower modulus 375 













samples without gelatin, with modulus value in the range of 3.51 - 4.76. The samples CG4 and CG8, 377 
crosslinked with PEGDA, which has the lowest averag molecular weight, have highest modulus 378 
value, while the samples CG2 and CG6 show the lowest modulus values in their respective groups. 379 
The values for Young modulus decrease with the increase of average molecular weight of the 380 
PBAE crosslinker and are in accordance with the degree of swelling, showing the mutual influence 381 
of crosslinker molecular weight and its hydrophilic/hydrophobic nature. Values for elongation at 382 
break follow a similar trend to Young’s modulus values, in the range of 22.85 - 28.24 % for 383 
cryogels without gelatine, with slightly lower values for cryogels with gelatin, in the range of 20.26 384 
- 26.17 %. It can be concluded that mechanical properties of synthesized IPNs can be tuned by 385 
changing the crosslinker component. 386 
 387 
3.8. Degradation studies  388 
Hydrolytic degradation of polymer networks is generally complex. Main properties that influence 389 
the degradation are: crosslink density, hydrophilicity/hydrophobicity, swelling capacity, surface 390 
charges and topography, specimen thickness, pH and ionic strength of the solution, and interaction 391 
between two hydrogel networks in the case of IPNs. In addition, the relative concentration of the 392 
components during polymerization is also important [36].  393 
Another important parameter influencing the hydrolytic degradation of investigated 394 
PHEMA/gelatin IPNs and PHEMA networks, is also the ype of PBAE macromer. The macromers 395 
used in this study were designed in order to obtain tunable rates of degradation, allowing for a 396 
variety of degradation profiles for samples with and without gelatin (Fig. 7).  397 
 398 
Fig. 7. Percentage of weight loss for cryogels with and without gelatin after 16 weeks. 399 
 400 
Among the cryogels with PBAE crosslinkers, CG3 exhibits the slowest degradation rate, 401 
presumably due to the hydrophobic structure of HDDA in CL3 crosslinker. The more hydrophilic 402 
nature of the PBAE crosslinkers with DEGDA, in samples CG1 and CG2, allows more water 403 
molecules to enter the cryogel network, resulting in faster degradation. Longer PBAE chains in CL2 404 
macromer, and lower crosslinking density in CG2 additionally sped up degradation rates. Therefore, 405 
CG2 scaffold showed the highest rate of degradation, with fractional mass loss of 32.71 ± 1.65 % 406 
after the period of 16 weeks. The degradation rates of CG3 and CG1 were lower, with respective 407 
mass loss of 21.4 ± 1.60 % and 25.95 ± 1.58 % after 16 weeks. CG4 showed less than 8% 408 
degradation (Table 2). 409 
Addition of gelatin slowed down the hydrolytic degradation rates of cryogels. Analogue of CG2, 410 
cryogel CG6 showed the highest rate of degradation, with fractional mass loss of 26.54 ± 0.67 % 411 













20.87 ± 0.94 % and 15.95 ± 0.76 % after 16 weeks. In the same period sample CG8 showed less 413 
than 5% degradation. 414 
 415 
3.9. Biocompatibility testing 416 
Results of biocompatibility testing showed a very satisfying biocompatibility of the tested 417 
hydrogels containing gelatin (Fig. 8). Biocompatibility is expressed as a high percent of viable 418 
normal human fibroblast after 24 hours treatment with prepared cryogel supernatants. Viability of 419 
MRC5 cells after treatment with prepared cryogels-supernatants was higher than 90 % for all test 420 
samples with gelatin, showing 20% or higher increase in viability, compared to hydrogels without 421 
gelatin.   422 
 423 
Fig. 8. Effect of supernatants of cultivated cryogels to viability of normal human fibroblast (MRC5 424 
cell line). 425 
 426 
Results represent mean +/- standard error of percent of viable cells after 24h treatment with 427 
supernatants of new synthetized hydrogels. This is representative experiment of two/three 428 
performed experiments. 429 
 430 
Acknowledgments: This work was financed by the SCOPES programme of the Swiss National 431 
Science Foundation (SNSF) and the Swiss Agency for Development and Cooperation (SDC) 432 
[Grants No IZ73ZO_152327].  433 
This work has been supported by the Ministry for Education, Science and Technological 434 
Development of the Republic of Serbia [Grant No 172062 and 176018]. 435 
 436 
 437 
4. Conclusion 438 
Novel degradable HEMA/gelatin based IPNs with different PBAE crosslinkers were successfully 439 
fabricated and characterized. Additional cryogel samples without gelatin were synthesized to assess 440 
the effects of gelatin addition and IPN formation on cryogel properties. Cryogels displayed different 441 
morphologies, porosity, and swelling and degradation rates based solely on the structure of PBAE 442 
crosslinker. The addition of gelatin increased the porosity of the cryogels, along with the swelling 443 
and degradation rates, which resulted in slightly reduced mechanical strength. All cryogels 444 
containing gelatin showed great biocompatibility, with MRC5 viability (over 90%). 445 
The results obtained indicate that PHEMA/gelatin IPNs have favourable swelling and mechanical 446 
characteristics, along with slow degradation rates, which can be tuned by changing PBAE 447 













regeneration. Aditional studies are required to asses  biocompatibility and degradation of the 449 
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Synthesis and characterization of novel biodegradable poly(2-hydroxyethyl 
metacrylate)/gelatine based IPN scaffolds.  
 
Tunable IPN scaffold properties with different PBAE crosslinkers for HEMA networks.   
 
The advantages of gelatine containing IPNs, due to the combination of natural and synthetic 
hydrogel, confirmed by comparison with a second set of cryogels without gelatine. 
 
High viability with MRC5 cells validated for all novel IPNs. 
  
